Table 3.
Comparison of intervention effects to the minimal clinically important difference (MCID) in the Fugl–Meyer assessment of the upper extremity (FMA-UE), wolf motor arm function test (WMFT), WMFT-FAS, and action research arm test (ARAT) assessments.
| Group | T2 - baseline | |||
|---|---|---|---|---|
| MCID | Mean | Percentage | ||
| FMA-UE | CT | 9 | 7.56 | 22.22% (2/9) |
| RBMT | 9.20 | 70% (7/10)* | ||
| WMFT-FAS | CT | 0.3 | 0.46 | 66.67% (6/9) |
| RBMT | 0.63 | 90.00% (9/10) | ||
| WMFT-time (s) | CT | 9 | 14.93 | 33.33% (3/9) |
| RBMT | 18.02 | 40.00% (4/10) | ||
| ARAT | CT | 12 | 9.10 | 22.22% (2/9) |
| RBMT | 5.78 | 40.00% (4/10) | ||
*
p < 0.05, Chi-squared test.